Search results for #HemOnc
What is VEXAS syndrome, and what is its association with MDS? 🤔 We interviewed Mael Heiblig of @CHUdeLyon to find out about this entity, which was first defined only a few years ago. Click here to watch: 👉 ow.ly/Ov5r50Rn4pi #ESHMDS2024 #MDSsm #HemOnc @EHA_Hematology
Welcoming @ASkarbnik soon at the First annual #HemOnc Pulse live meeting #HOPLive24 @Blood_Cancers where he will be a panelist at the DLBCL, CLL, and CART sessions addressing "Unanswered Questions" in these disciplines. Follow here for more updates soon. Countdown starting.
@SridharChaganti (@uhbtrust) comments on how #CART therapy for ALL & #Lymphoma can be improved, discussing allogeneic products & CRS/ICANS prophylaxis: 👉 ow.ly/x3OP50RnkfZ #ALLsm #Leusm #Leukemia #LYMsm #CARTCell #ImmunoOnc #HemOnc @TheEBMT
This week, the first annual #HemOnc Pulse meeting #HOPLive24 is happ in Chicago. @Ramikomrokji will present “Unanswered Questions” in MDS, which will be discussed by @drsangeetmd @sanamloghavi @Dr_AmerZeidan & Dr. Shammo (not on @X) We will have that as a future podcast.
he will be in Chicago at the First annual #HemOnc Pulse LIVE #HOPLive24 amongst faculty tackling "Unanswered Questions" in Heme Cancers. @AaronGoodman33 will be a panelist on the Bispecifics & Myeloma sessions & expect fireworks - he is also MOC-ready. @Blood_Cancers Stay tuned
Want to learn more about the treatment of steroid-refractory #GvHD & the role of the gut microbiome in the severity of GvHD? Listen to our latest podcast with expert insights: 🎧 ow.ly/ybFF50RoVKl #BMTsm #HemOnc
@MyelomaAmateur @barttels2 @AaronGoodman33 @VincentRK @Rfonsi1 @szusmani @jmikhaelmd The podcasts will start airing after the meeting concludes but rest assured there will be lots of updates and video interviews on Twitter throughout this event, #HOPLive24 #HemOnc Pulse podcast.
The amazing @sanamloghavi of @MDAndersonNews will be in Chicago at the first annual #HemOnc Pulse LIVE #HOPLive24. Sanam will be at the MPN, MDS, & ALL sessions teaching us more Hempath in these and other sessions. Stay tuned & join the conversation. bloodcancerstoday.com/post/sanam-log…
It was lovely to speak with @DeeptiRadia about the current therapeutic landscape for systemic mastocytosis and the unmet needs and challenges that remain in this space. All of our interviews from #BSH2024 will be on VJHemOnc.com 🔜 @BritSocHaem #HemOnc
Always a pleasure to catch up w/ @harrisoncn1 (@GSTTnhs)!😊 Keep an eye out on VJHemOnc.com for a deep dive into the current MPN trials in the UK, treatment approaches for pts with #Myelofibrosis who are ineligible for ruxolitinib, & more! #BSH2024 #MPNsm #HemOnc…
Gregoire Le Gal spoke with us today on a study investigating enoxaparin versus placebo to prevent symptomatic venous thromboembolism in hospitalized older adults. This and more from #BSH2024 will be on VJHemOnc.com soon! @BritSocHaem #HemOnc #VTE #thrombosis
Many thanks to Beverley Hunt (@bhwords) for sharing insights into thromboprophylaxis clinical trials in pregnant women, reducing the risk of atherosclerosis in patients with haemophilia, and more! Stay tuned on VJHemOnc.com! #BSH2024 #HemOnc @BritSocHaem…
This week: First annual #HemOnc Pulse LIVE #HOPLive24. I am hosting top faculty from all over the country debating "Unanswered Questions" In Heme Cancers. Stay tuned 4 many. @VincentRK @Rfonsi1 @sanamloghavi @drsangeetmd @AaronGoodman33 @ASkarbnik @doctorpemm @mpdrc & many more.
Few days until the first annual #HemOnc Pulse LIVE all star meeting #HOPLive24 - “Unanswered Questions” in Heme Cancers. @VincentRK will present on myeloma while @Rfonsi1 @AaronGoodman33 @szusmani & @jmikhaelmd challenge him. Stay tuned.
A wonderful interview with @AnupamaGRao (@GreatOrmondSt), taking a deep dive into pediatric hematology and the hematological predispositions to AML!🩸 🔜 Coming soon on VJHemOnc.com! #AMLsm #Leukemia #Leusm #CaGenome #BSH2024 #HemOnc @BritSocHaem
We just spoke with @lilyscourfield (@KingsCollegeNHS), who discussed outcomes for patients who are referred to intensive care units following CAR-T therapy. Stay tuned on VJHemOnc.com for more insights from #BSH2024! #CART @BritSocHaem #HemOnc
It was lovely to speak with Kanagaraju Ponnusamy (@imperialcollege) at #BSH2024, who shared insights into novel iNKT-CAR T-cells for hematological malignancies and their mechanism of action. @BritSocHaem #HemOnc #CART
Economic sustainability of cancer care & cancer care in areas of conflict are both pertinent issues in the field of #HemOnc.💭 We caught up with @SullivanProf (@KingsCollegeLon) to hear about these topics, and we look forward to sharing the interview soon! #BSH2024 #GlobOnc…
It is our second day on-site at #BSH2024! 🩸 We have had some wonderful conversations with leading experts so far.😊 Keep an eye out for our exclusive interviews coming soon! 🎥 🔜 VJHemOnc.com @BritSocHaem #HemOnc #Hematology
We just caught up with Mary Frances McMullin from @queensubelfast, who gave an insight into the management of #Myelofibrosis in patients w/ anemia, the current BSH guidelines for diagnosis & evaluation of prognosis of the disease, & more! #BSH2024 #HemOnc #MPNsm @BritSocHaem